Haw Par Corporation Limited (SGX:H02)

Verve Therapeutics Income Statement

Financials in millions SGD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	244.82	232.06	182.09	141.18	111.03
Revenue Growth (YoY)	5.50%	27.44%	28.98%	27.15%	-54.49%
Cost of Revenue	110.74	97.17	83.53	67.54	62.21
Gross Profit	134.09	134.89	98.57	73.64	48.83
Selling, General & Admin	70.25	70.88	55.19	48.95	34.9
Operating Expenses	70.25	70.88	55.19	48.95	34.9
Operating Income	63.84	64.01	43.38	24.7	13.93
Interest Expense	-2.09	-1.56	-0.53	-0.03	-0.08
Interest & Investment Income	178.79	162.14	111.75	86.57	102.65
Earnings From Equity Investments	4.2	3.51	3.13	3.22	3.52
Other Non Operating Income (Expenses)	1.37	1.28	1.24	1.72	4.19
EBT Excluding Unusual Items	246.12	229.39	158.97	116.18	124.21
Pretax Income	246.12	229.39	158.97	116.18	124.21
Income Tax Expense	17.84	12.83	10.65	6.08	4.43
Net Income	228.27	216.57	148.32	110.1	119.77
Net Income to Common	228.27	216.57	148.32	110.1	119.77
Net Income Growth	5.41%	46.02%	34.71%	-8.07%	-34.27%
Shares Outstanding (Basic)	221	221	221	221	221
Shares Outstanding (Diluted)	221	221	221	221	221
Shares Change (YoY)	-	-	0.03%	0.05%	0.02%
EPS (Basic)	1.03	0.98	0.67	0.50	0.54
EPS (Diluted)	1.03	0.98	0.67	0.50	0.54
EPS Growth	5.41%	46.02%	34.65%	-8.12%	-34.28%
Free Cash Flow	50.33	54.92	21.21	14.46	17.49
Free Cash Flow Per Share	0.23	0.25	0.10	0.07	0.08
Dividend Per Share	0.400	0.400	0.300	0.300	0.300
Dividend Growth	-	33.33%	-	-	-
Gross Margin	54.77%	58.13%	54.13%	52.16%	43.98%
Operating Margin	26.08%	27.58%	23.82%	17.49%	12.55%
Profit Margin	93.24%	93.32%	81.45%	77.99%	107.87%
Free Cash Flow Margin	20.56%	23.66%	11.65%	10.24%	15.75%
EBITDA	69.74	69.85	48.85	31.16	20.47
EBITDA Margin	28.48%	30.10%	26.83%	22.07%	18.44%
D&A For EBITDA	5.89	5.83	5.47	6.46	6.54
EBIT	63.84	64.01	43.38	24.7	13.93
EBIT Margin	26.08%	27.58%	23.82%	17.49%	12.55%
Effective Tax Rate	7.25%	5.59%	6.70%	5.23%	3.57%

Updated Feb 21, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.